Vitreous Humor: Composition, Characteristics and Implication on Intravitreal Drug Delivery

References

• WHO. World report on vision. 2019.
   Google Scholar
• Harding S. Extracts from “concise clinical evidence”. BMJ. 2003;326(7397):1023–1025. doi:10.1136/bmj.326.7397.1023.
   PubMed Web of Science ®Google Scholar
• Hannover A. Mikroskopiske undersögelser af nervesystemet. 1842.
   Google Scholar
• Höhn A, König J, Grune T. Protein oxidation in aging and the removal of oxidized proteins. J Proteomics. 2013;92:132–159. doi:10.1016/j.jprot.2013.01.004.
   PubMed Web of Science ®Google Scholar
• Lucentis® (ranibizumab). Abbreviated UK prescribing information. Eye. 2017;31:S18–S20. doi:10.1038/eye.2017.149.
   PubMed Web of Science ®Google Scholar
• Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, Dugel PU, Freund KB, Glassman AR, Kim JE, for the American Society of Retina Specialists Anti-VEGF for Diabetic Macular Edema Comparative Effectiveness Panel, et al. Comparison of aflibercept, bevacizumab, and ranibizumab for treatment of diabetic macular edema: extrapolation of data to clinical practice. JAMA Ophthalmol. 2016;134(1):95–99. doi:10.1001/jamaophthalmol.2015.4110.
   PubMed Web of Science ®Google Scholar
• Squibb B-M. Kenalog for intramuscular or intra-articular use only (pp. 1–20). 2016.
   Google Scholar
• Parenky AC, Wadhwa S, Chen HH, Bhalla AS, Graham KS, Shameem M. Container closure and delivery considerations for intravitreal drug administration. AAPS PharmSciTech. 2021;22(3):1–13. doi:10.1208/s12249-021-01949-4.
   Web of Science ®Google Scholar
• US FDA. FULL PRESCRIBING INFORMATION for ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg For Intravitreal Injection. FDA.GOV, 2014. Reference ID: 3635981. 19631–10. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201923s000lbl.pdf
   Google Scholar
• Eter N, Mohr A, Wachtlin J, Feltgen N, Shirlaw A, Leaback R; German Ozurdex in RVO Real World Study Group. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial. Graefes Arch Clin Exp Ophthalmol. 2017;255(1):77–87. doi: 10.1007/s00417-016-3431-x.
   Google Scholar
• YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg, for intravitreal injection. FDA.GOV., NDA 21-737/S-007. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021737s000_AdminCorres.pdf
   Google Scholar
• E. P. P. I. YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg, for intravitreal injection. yutiq.com. 1963. https://yutiq.com/downloads/YUTIQ-USPI-20181120.pdf
   Google Scholar
• Heimann F, Barteselli G, Brand A, Dingeldey A, Godard L, Hochstetter H, Schneider M, Rothkegel A, Wagner C, Horvath J, et al. A custom virtual reality training solution for ophthalmologic surgical clinical trials. Adv Simul. 2021; 6(1):7. doi:10.1186/s41077-021-00167-z.
   PubMedGoogle Scholar
• Massa H, Georgoudis P, Panos GD. Dexamethasone intravitreal implant (OZURDEX®) for macular edema secondary to noninfectious uveitis: a review of the literature. Ther Deliv. 2019;10(6):343–351. doi:10.4155/tde-2019-0024.
   PubMed Web of Science ®Google Scholar
• Genentech, Inc., Study of the efficacy and safety of the ranibizumab port delivery system for sustained delivery of ranibizumab in patients with subfoveal neovascular age-related macular degeneration (LADDER), NCT02510794, Updated May 6, 2021. Accessed November 24, 2022. https://clinicaltrials.gov/ct2/show/NCT02510794
   Google Scholar
• Holekamp NM, Campochiaro PA, Chang M, Miller D, Pieramici D, Adamis AP, Brittain C, Evans E, Kaufman D, Maass KF, all Archway Investigators, et al. Archway randomized phase 3 trial of the port delivery system with ranibizumab for neovascular age-related macular degeneration. Ophthalmology. 2022;129(3):295–307. doi:10.1016/j.ophtha.2021.09.016.
   PubMed Web of Science ®Google Scholar
• García-Quintanilla L, Luaces-Rodríguez A, Gil-Martínez M, Mondelo-García C, Maroñas O, Mangas-Sanjuan V, González-Barcia M, Zarra-Ferro I, Aguiar P, Otero-Espinar FJ, et al. Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration. Pharmaceutics. 2019;11(8):365. doi:10.3390/PHARMACEUTICS11080365.
   PubMed Web of Science ®Google Scholar
• Sebag J. Imaging vitreous. Eye. 2002;16(4):429–439. doi:10.1038/SJ.EYE.6700201.
   PubMed Web of Science ®Google Scholar
• Le Goff MM, Bishop PN. Adult vitreous structure and postnatal changes. Eye. 2008;22(10):1214–1222. doi:10.1038/eye.2008.21.
   PubMed Web of Science ®Google Scholar
• Peng Y, Yu Y, Lin L, Liu X, Zhang X, Wang P, Hoffman P, Kim SY, Zhang F, Linhardt RJ. Glycosaminoglycans from bovine eye vitreous humour and interaction with collagen type II. Glycoconj J. 2018;35(1):119–128. doi:10.1007/s10719-017-9808-1.
   PubMed Web of Science ®Google Scholar
• Tram NK, Swindle-Reilly KE. Rheological properties and age-related changes of the human vitreous humor. Front Bioeng Biotechnol. 2018; 6:199. doi:10.3389/FBIOE.2018.00199/BIBTEX.
   PubMed Web of Science ®Google Scholar
• Fernald RD, Wright SE. Maintenance of optical quality during crystalline lens growth. Nature. 1983;301(5901):618–620. doi:10.1038/301618a0.
   PubMed Web of Science ®Google Scholar
• Patel S, Tutchenko L. The refractive index of the human cornea: a review. Cont Lens Anterior Eye. 2019;42(5):575–580. doi:10.1016/j.clae.2019.04.018.
   PubMed Web of Science ®Google Scholar
• Silva AF, Alves MA, Oliveira MSN. Rheological behaviour of vitreous humour. Rheol Acta. 2017;56(4):377–386. doi:10.1007/s00397-017-0997-0.
   Web of Science ®Google Scholar
• Bishop PN, Crossman MV, McLeod D, Ayad S. Extraction and characterization of the tissue forms of collagen types II and IX from bovine vitreous. Biochem J. 1994;299(2):497–505. doi:10.1042/bj2990497.
   PubMed Web of Science ®Google Scholar
• Canty-Laird EG, Lu Y, Kadler KE. Stepwise proteolytic activation of type I procollagen to collagen within the secretory pathway of tendon fibroblasts in situ. Biochem J. 2012;441(2):707–717. doi:10.1042/BJ20111379.
   PubMed Web of Science ®Google Scholar
• Shafaie S, Hutter V, Brown MB, Cook MT, Chau DYS. Diffusion through the ex vivo vitreal body – bovine, porcine, and ovine models are poor surrogates for the human vitreous. Int J Pharm. 2018;550(1–2):207–215. doi:10.1016/j.ijpharm.2018.07.070.
   PubMed Web of Science ®Google Scholar
• Boneva SK, Wolf J, Rosmus DD, Schlecht A, Prinz G, Laich Y, Boeck M, Zhang P, Hilgendorf I, Stahl A, et al. Transcriptional profiling uncovers human hyalocytes as a unique innate immune cell population. Front Immunol. 2020;11:1–14. doi:10.3389/fimmu.2020.567274.
   PubMed Web of Science ®Google Scholar
• Ashworth JL, Kielty CM, McLeod D. Fibrillin and the eye. Br J Ophthalmol. 2000;84(11):1312–1317. doi:10.1136/bjo.84.11.1312.
   PubMed Web of Science ®Google Scholar
• Le Goff MM, Lu H, Ugarte M, Henry S, Takanosu M, Mayne R, Bishop PN. The vitreous glycoprotein opticin inhibits preretinal neovascularization. Invest Ophthalmol Vis Sci. 2012;53(1):228–234. doi:10.1167/iovs.11-8514.
   PubMed Web of Science ®Google Scholar
• Lindahl U, Couchman J, Kimata K. Proteoglycans and sulfated glycosaminoglycans. In Varki A, Cummings R, Esko J (Eds.). Essentials of glycobiology, 2015.
   Google Scholar
• Kim H, Lizak MJ, Tansey G, Csaky KG, Robinson MR, Yuan P, Wang NS, Lutz RJ. Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging. Ann Biomed Eng. 2005;33(2):150–164. doi:10.1007/s10439-005-8974-7.
   PubMed Web of Science ®Google Scholar
• del Amo EM, Rimpelä AK, Heikkinen E, Kari OK, Ramsay E, Lajunen T, Schmitt M, Pelkonen L, Bhattacharya M, Richardson D, et al. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 2017;57:134–185. doi:10.1016/j.preteyeres.2016.12.001.
   PubMed Web of Science ®Google Scholar
• Huerta Ángeles G, Nešporová K. Hyaluronan and its derivatives for ophthalmology: recent advances and future perspectives. Carbohydr Polym. 2021;259:117697. doi:10.1016/j.carbpol.2021.117697.
   PubMed Web of Science ®Google Scholar
• Loukovaara S, Nurkkala H, Tamene F, Gucciardo E, Liu X, Repo P, Lehti K, Varjosalo M. Quantitative proteomics analysis of vitreous humor from diabetic retinopathy patients. J Proteome Res. 2015;14(12):5131–5143. doi:10.1021/acs.jproteome.5b00900.
   PubMed Web of Science ®Google Scholar
• Sotoodehnejadnematalahi F, Burke B. Structure, function and regulation of versican: the most abundant type of proteoglycan in the extracellular matrix. Acta Med Iran. 2013;51(11):740–750.
   PubMedGoogle Scholar
• Keenan TDL, Pickford CE, Holley RJ, Clark SJ, Lin W, Dowsey AW, Merry CL, Day AJ, Bishop PN. Age-dependent changes in heparan sulfate in human Bruch’s membrane: implications for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55(8):5370–5379. doi:10.1167/iovs.14-14126.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang Q, Filas BA, Roth R, Heuser J, Ma N, Ma N, Sharma S, Panitch A, Beebe DC, et al. Preservation of the structure of enzymatically-degraded bovine vitreous using synthetic proteoglycan mimics. Invest Ophthalmol Vis Sci. 2014;55(12):8153–8162. doi:10.1167/iovs.14-14366.
   PubMed Web of Science ®Google Scholar
• Beebe DC, Holekamp NM, Siegfried C, Shui YB. Vitreoretinal influences on lens function and cataract. Philos Trans R Soc Lond B Biol Sci. 2011;366(1568):1293–1300. doi:10.1098/rstb.2010.0228.
   PubMed Web of Science ®Google Scholar
• Meral I, Bilgili Y. Diffusion changes in the vitreous humor of the eye during aging. AJNR Am J Neuroradiol. 2011;32(8):1563–1566. doi:10.3174/AJNR.A2543.
   PubMed Web of Science ®Google Scholar
• Käsdorf BT, Arends F, Lieleg O. Diffusion regulation in the vitreous humor. Biophys J. 2015;109(10):2171–2181. doi:10.1016/j.bpj.2015.10.002.
   PubMed Web of Science ®Google Scholar
• Smith DW, Lee CJ, Gardiner BS. No flow through the vitreous humor: how strong is the evidence? Prog Retin Eye Res. 2020;78:100845. doi:10.1016/J.PRETEYERES.2020.100845.
   Web of Science ®Google Scholar
• Dörsam S, Olkhovskiy V, Friedmann E. Modeling and simulation of the aqueous humor flow in the human eye. Proc Appl Math Mech. 2019;19(1):e201900462. doi:10.1002/PAMM.201900462.
   Google Scholar
• Colter J, Williams A, Moran P, Coats B. Age-related changes in dynamic moduli of ovine vitreous. J Mech Behav Biomed Mater. 2015;41:315–324. doi:10.1016/j.jmbbm.2014.09.004.
   PubMed Web of Science ®Google Scholar
• Nickerson CS, Karageozian HL, Park J, Kornfield JA. The mechanical properties of the vitreous humor. Invest Ophthalmol Vis Sci. 2004;45(13):37.
   Google Scholar
• Lee B, Litt M, Buchsbaum G. Rheology of the vitreous body: Part 3. Concentration of electrolytes, collagen and hyaluronic acid. Biorheology. 1994;31(4):339–351. doi:10.3233/BIR-1994-31404.
   PubMed Web of Science ®Google Scholar
• Weber H, Landwehr G, Kilp H, Neubauer H. The mechanical properties of the vitreous of pig and human donor eyes. Ophthalmic Res. 1982;14(5):335–343. doi:10.1159/000265211.
   PubMed Web of Science ®Google Scholar
• Los LI, Van der Worp RJ, Van Luyn MJA, Hooymans JMM. Age-related liquefaction of the human vitreous body: LM and TEM evaluation of the role of proteoglycans and collagen. Invest Ophthalmol Vis Sci. 2003;44(7):2828–2833. doi:10.1167/IOVS.02-0588.
   PubMed Web of Science ®Google Scholar
• Goldmann H. Slit-lamp examination of the vitreous and the fundus. Br J Ophthalmol. 1949;33(4):242–247. doi:10.1136/BJO.33.4.242.
   PubMed Web of Science ®Google Scholar
• Basile AS, Glazier G, Lee A, Jiang L-Y, Johnson TR, Shields MJ, Vezina M, Doppalapudi VR. Intravitreal concentrations of a near-infrared fluorescence–labeled biotherapeutic determined in situ using confocal scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci. 2011;52(9):6949–6958. doi:10.1167/iovs.11-7790.
   PubMed Web of Science ®Google Scholar
• Lahham S, Shniter I, Thompson M, Le D, Chadha T, Mailhot T, Kang TL, Chiem A, Tseeng S, Fox JC. Point-of-care ultrasonography in the diagnosis of retinal detachment, vitreous hemorrhage, and vitreous detachment in the emergency department. JAMA Netw Open. 2019;2(4):e192162–e192162. doi:10.1001/jamanetworkopen.2019.2162.
   Web of Science ®Google Scholar
• Mamou J, Wa CA, Yee KMP, Silverman RH, Ketterling JA, Sadun AA, Sebag J. Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life. Invest Ophthalmol Vis Sci. 2015;56(3):1611–1617. doi:10.1167/iovs.14-15414.
   PubMed Web of Science ®Google Scholar
• Höhn F, Mirshahi A, Hattenbach L-O. Optical coherence tomography for diagnosis of posterior vitreous detachment at the macular region. Eur J Ophthalmol. 2009;19(3):442–447. doi:10.1177/112067210901900319.
   PubMed Web of Science ®Google Scholar
• Fanea L, Fagan AJ. Review: magnetic resonance imaging techniques in ophthalmology. Mol Vis. 2012;18:2538–2560.
   PubMed Web of Science ®Google Scholar
• Erckens RJ, Jongsma FHM, Wicksted JP, Hendrikse F, March WF, Motamedi M. Raman spectroscopy in ophthalmology: from experimental tool to applications in vivo. Lasers Med Sci. 2001;16(4):236–252. doi:10.1007/PL00011360.
   PubMed Web of Science ®Google Scholar
• Method for non-invasive identification of individuals at risk for diabetes. 1999.
   Google Scholar
• von Bülow S, Siggel M, Linke M, Hummer G. Dynamic cluster formation determines viscosity and diffusion in dense protein solutions. Proc Natl Acad Sci USA. 2019;116(20):9843–9852. doi:10.1073/pnas.1817564116.
   PubMed Web of Science ®Google Scholar
• Neudorfer M, Fuhrer AE, Zur D, Barak A. The role of posterior vitreous detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration. Indian J Ophthalmol. 2018;66(12):1802. doi:10.4103/ijo.IJO_373_18.
   PubMed Web of Science ®Google Scholar